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Introduction
Gamal Ghoniem
Background
Millions of women are afflicted with stress urinary
incontinence (SUI) and pelvic organ prolapse (POP) around
the globe, and the literature is abundant with different types
of surgery to correct these problems. Only recently have
outcome measures been applied to research in these areas.
There are great variations in types of surgery performed,
secondary to many factors such as surgeon’s training and
socioeconomic factors. As the population of aging women
increases worldwide, it is inevitable that these women’s
disorders will become more prevalent. This will pose a
major challenge to the health care systems.
Objectives
The field exploring and treating pelvic floor disorders is
evolving rapidly, and guidelines should be developed and
updated every few years so that the most recent evidence-
based medicine is incorporated.
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Based on our meeting at the IUGA/ICS Joint Meeting in
Paris (August 2004), the IUGA Research and Development
Committee (RDC) developed the following steps to
accomplish the objectives:
1- Review recent English literature
2- Review outcome measures (primary and secondary)
3- Prepare recommendations
4- Define and consult expert opinions
5- Write a white paper to circulate among members
utilizing the IUGA web site
6- Final revision after feedback from members
7- Publish in IUJ
In a subsequent meeting during the IUGA Annual
Meeting in Copenhagen (August, 2005), the outlines of
the work were discussed, revised, and divided among the
members.
Index case
The index case is that of an otherwise healthy female with
stress urinary incontinence with or without pelvic organ
prolapse.
Materials and methods
A combination of a systematic review of literature (MED-
LINE®), Cochrane database, ICI (International Consulta-
tion on Incontinence) recommendations, and expert
opinion, including history, physical examination, question-
naires, tests, surgical treatment, outcome measures, and
follow-up were evaluated and categorized into:
– Recommended
– Optional
– Not recommended
Methods of review
The methodological quality and appropriateness of selected
studies and data extraction rested solely on the judgment of
each author, reviewed by experts, and subsequently made
available for review by the IUGA membership. The
outcomes were evaluated into primary and secondary
measures by the RDC.
Primary Secondary
Initial clinical evaluation Urodynamic testing
Voiding diary Neurophysiological testing
Stress testing Surgical complications
Grading of SUI and Pad testing Cost effectiveness
Quality of life measures
Urethral mobility
Patient satisfaction
Prolapse assessment
Initial clinical evaluation
Gamal Ghoniem
Clinical assessment
Assessment of patient expectation, and social and econom-
ical factors are important in choosing treatment. Lifestyle
adjustment, behavioral modifications, and dietary manage-
ment may benefit some patients.
History
General history, including drug, obstetrical, surgical,
bowel and neurological evaluation should be part of the
exam. The type of incontinence determined from taking the
history, whether stress, urge, or mixed, is used to direct
treatment. There is low correlation between urodynamic
findings and symptoms of urge incontinence. However,
women with pure stress incontinence symptoms are also
unlikely to have detrusor overactivity on urodynamics [1].
Physical examination
Genitourinary examination should include determination of
estrogenic status of the vagina, caliber, description of
interstitial or vaginal masses, and neurological examination.
Sensation and bulbo-cavernosus reflex should be checked.
Pelvic floor muscle evaluation
Pelvic floor muscle (PFM) evaluation can be performed by
instructing a woman in PFM contraction, with measure and
documenting of PFM contraction at initial evaluation and
throughout treatment. Various tests measure different aspects
of PFM function. Although ultrasound and magnetic reso-
nance imaging (MRI) are more objective measurements of
PFM, vaginal palpation is standard when assessing the ability
to contract the PFM. Further research is required to determine
reliability and validity scores for imaging techniques [2].
Urinalysis
Urinary tract infection (UTI) is an easily treatable cause of
lower urinary tract symptoms (LUTS). Urine dipstick has
low sensitivity and high specificity to detect UTI. While a
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negative test indicates no UTI, a positive one correlates
with a positive culture in only one third of cases [3].
Urinalysis by dipstick is highly recommended in all patients
with incontinence Urine cultures (mid-stream) should be
performed in asymptomatic women with positive dipstick
and symptomatic women with negative dipstick.
Microscopic urinanalysis is recommended for patients with
microhematuria Urine cytology is indicated for patients
with proven microhematuria and undergoing the work-up to
exclude urinary neoplasm.
Residual urine
Residual urine may be measured by either a catheter or
ultrasound. There is a good clinical correlation between the
two methods [4]. The latter is non-invasive and can be used
when catheterization is not required. There is no consensus
as to the definition of large or high (abnormal) residual
volume values. Residual urine volumes should be deter-
mined in any woman with symptoms of voiding dysfunction,
or with a history of recurrent UTIs.
Cystoscopy
Bladder lesions are found in less than 2% of patients
with incontinence; therefore, cystoscopy should not be
performed routinely in patients with stress urinary
incontinence to exclude neoplasm [5]. It is recommended
in patients with irritative bladder symptoms in the absence
of infection. Cystoscopy is highly recommended for the
evaluation of patients with hematuria, which may be
indicative of bladder tumor. It is highly recommended for
urinary fistulae, including vesicovaginal and ureterovagi-
nal, and any suspected extra-urethral source of urinary
incontinence.
Cystoscopy is recommended when a reversible cause is
not found, in patients with pyuria or irritative voiding
symptoms, such as frequency, urgency, and urge inconti-
nence. It is recommended in patients with bladder pain and
LUTS; in recurrent cystitis; and in patients with suburethral
mass [6].
Blood tests
Standard metabolic evaluation of renal function with
measurement of serum creatinine and blood urea levels is
recommended when renal impairment is suspected.
Imaging
Imaging is not routinely recommended. It is indicated when
upper urinary tract pathology is suspected. Specific indica-
tions include neurogenic bladder, chronic high-grade pelvic
organ prolapse, low compliance of the bladder, or high
residual urine volumes.
Voiding diary
Gamal Ghoniem
Introduction
The voiding diary is a record of micturition behavior
completed by the patient. It is among the best possible
means of obtaining objective data on subjective symptoms
[7]. The International Continence Society (ICS) recom-
mends the inclusion of voiding diaries in the clinical
assessment of patients with LUTS [8]. There are various
terms used for voiding diaries, including micturition time or
frequency charts, frequency volume charts, and bladder or
urinary diaries. Recently, computerized voiding diaries
have been developed. A drawback of the computerized
diary may be a fear of technology, which is common in
certain patient populations such as the elderly [9]. Main-
taining a voiding diary involves patients in the management
of their condition, and helps them become an active partner
in the treatment process. Moreover, it provides them with
an objective assessment of their condition both during and
after treatment. Objective data (diary) does not necessarily
correlate with the degree of bother from incontinence (e.g.,
urge incontinence); each is a different aspect of evaluation.
It can be difficult for the patient to recall or judge voiding
frequency and pattern retrospectively, especially when
voiding behavior is irregular [10]. Bother depends on
recall, while a voiding diary is objective. McCormack et
al. [11] revealed poor agreement between subjectively
estimated urinary frequency and urinary frequency shown
on a chart. The diary also provides an evaluation of
treatment, which is more accurate than the history because
patients sometimes claim improvement, presumably to
please their doctors, when their diaries in fact show no
change. However, the diary is only supplemental to the
patient’s history, and both should be used to identify the
complaint and formulate an accurate diagnosis.
There are a number of different types of voiding
diaries, including a Frequency Chart, which is the
simplest type of voiding diary because the patient is asked
to record only micturition and incontinence episodes. A
frequency–volume chart requires the patient to record the
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amount of urine of each micturition, the time of each void,
and incontinence episodes [12]. Other parameters include
the number of pads used and estimated fluid intake in cups
or mugs.
Urgency may be recorded as 0, +, or ++, or on a scale
from 0–10, depending on the diary used. Urgency can also
be evaluated in minutes [13], by asking the patient to
estimate how long he or she could wait before voiding.
Diary duration
It has been shown that a complex long-term diary decreases
patient compliance with recording. A 3-day diary is long
enough to be reliable, and short enough to decrease patient
burden and increase compliance [14]. Nygaard and Holcomb
reported good correlation of 0.887 between the first 3 days of
a 7-day diary and the last 4 days [15]. They suggest that the
3-day diary is an appropriate outcome measure for clinical
trials, evaluating treatment of SUI.
Voiding diaries and patient history
The voiding diary represents a self-monitoring daily record
of the patient’s voiding behavior, whereas the history is
based on the patient’s recall, which is greatly affected by
the patient’s degree of bother. Patients are sometimes
surprised at the actual number of voiding events that occur
once they are asked to record them.
Using voiding diaries in incontinent patients
The primary use of voiding diaries in incontinent patients is
documentation of incontinence episodes. Diaries may
provide clues to the underlying cause of incontinence,
particularly if the diary includes patient comments about the
reason(s) or condition(s) associated with the incontinence
episodes. Voiding diaries can be used in evaluation of the
severity of urinary incontinence, as the patient may report
the number of incontinent episodes, number of pads used,
and the amount of leakage.
The diagnostic role of the diary can be limited. Utilizing
the voiding diary in patients with and without urge
incontinence, one study showed significant differences
between groups in frequency, mean voided volume, and
largest single voided volume, although the overlap was
large [16]. A similar study compared women with stress
urinary incontinence to a normal group, and surprisingly
showed that total voided volume, frequency of micturition,
and largest single voided volume were all significantly
higher in the genuine urinary stress incontinence group than
in the normal group [17].
The voiding diary has been used to differentiate between
urge and stress incontinence [18]. Most of these studies
have shown not only significant differences between
populations with urge and stress incontinence, but also
considerable overlap. Total voided volumes, mean voided
volumes, and largest single voided volumes were less in
urge incontinent than stress urinary incontinent groups.
Frequency of micturition during the day and at night was
more in the urge than in the stress incontinent groups.
Analysis of one of these studies showed that the frequency
of micturition at night was the single parameter that best
discriminates the two conditions. Combining daytime
micturition frequency with the largest single voided volume
or the mean voided volume increased the discrimination
power [18].
It is reasonable to evaluate incontinent patients with a
voiding diary before other more invasive tests such as
urodynamic investigation because it is a simple, noninva-
sive, and inexpensive tool. It evaluates the patient over a
longer period of time, away from the laboratory. If
urodynamic studies are indicated, a voiding diary can help
the clinician choose which studies should be performed. A
voiding diary is also reliable and valid when measuring the
symptoms of overactive bladder, including urge and urge
incontinence episodes, and nocturia [19].
Assessment of voiding dysfunction treatment
In addition to providing baseline measurements before
treatment, voiding diaries can be used to evaluate the
progress and efficacy of treatment. Recently, new medi-
cations for treatment of LUTS, including overactive
bladder, have been evaluated in clinical trials. All of these
medications are directed at symptom improvement; there-
fore, patient-completed voiding diaries are commonly used
in evaluation of the effectiveness of these drugs [20, 21].
This application also explains the recent increase in the
number of published studies utilizing the voiding diary.
Voiding diaries can be used to evaluate treatment
modalities other than pharmacotherapy, such as surgery and
behavioral therapy. For example, they can provide a baseline
assessment before anti-incontinence surgery and evaluate
outcome after the procedure. With behavioral therapy,
changes and improvement occur gradually due to learning
and the time it takes to strengthen muscles. These gradual
changes are often unnoticed by the patient, but are measured
and documented objectively in the diary. Objective feedback
about such small changes can help the patient maintain the
motivation and persistence needed for a successful outcome.
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Research and asymptomatic populations
Voiding diaries have been used to define normal urinary
measurements and physiological differences between normal
populations. Most of the published data on urinary diaries
have been obtained in women. Several studies established
normal values for healthy females [22–23]. Data obtained
from frequency–volume charts of normal females showed
that mean voided volume was 230 to 250 ml, mean
frequency was 5.7 to 7.3, and total voided volume was
1,272 to 1,350 ml. Two of these studies analyzed diurnal and
nocturnal data separately [24, 25]. This may be important,
because nighttime diuresis may exceed daytime diuresis and
may be responsible for nocturia, especially in the elderly.
Fitzgerald et al. [26] studied urinary habits with voiding
diaries in asymptomatic women and reported that diary
variables are affected by age, race, and fluid intake. Voids
per liter intake varied with age and were higher among
parous and Asian women. The number of nighttime voids
depended only on patient age. The mean and maximum
voided volumes were lower among black women.
Conclusions and recommendations
The voiding diary is highly recommended in clinical
research and optional in the clinical practice of female
urinary incontinence. The 3-day diary is practical, has a high
patient acceptance and compliance, and it correlates well
with the 7-day diary.
Stress test
Teresa Mascarenhas
Introduction
Several studies have demonstrated that the diagnosis of a
specific type of incontinence based on a simple history and
physical examination is extremely unreliable, and clinical
decisions regarding treatment should be based on special-
ized testing [27].
The techniques for the evaluation of the incontinent
patient range in complexity from a simple cough stress test
to video fluorourodynamics [28]. In a cost-conscious
society, having a test that is easy to perform, inexpensive,
and also diagnostically reliable would be of great value to
physicians managing women with urinary incontinence.
The cough stress test can be performed with the bladder
empty or with the patient’s bladder filled up to 300 ml or to
subjective fullness [27], and then, while in an upright or
lithotomy position, having the patient perform a series of
forceful coughs. The external urethral meatus is observed
during the coughs for gross urine loss. If urine loss is noted,
the test is positive with a diagnosis of stress urinary
incontinence. The cough stress test has been compared with
other sophisticated testing methods (multichannel urody-
namics studies) and has demonstrated good sensitivity and
specificity in the diagnosis of genuine stress incontinence
[28–30]. However, the reproducibility of the results of this
technique need to be demonstrated to gain widespread
application, which includes establishing the reliability and
validity of the test. Reliability means the ability of the test to
be consistent and stable, i.e., reproducible.
A few clinical trials and studies have been conducted and
published on the evaluation of the reliability of the cough
stress test as a diagnostic test. This test is widely used as part
of the clinician’s physical examination of the patient for both
diagnosis and also as an outcome measure after treatment.
The test is mainly used in conjunction with other urody-
namic testing; thus, it is difficult to evaluate its reliability in
comparison with more sophisticated and expensive testing
methods such as multichannel urodynamics.
The parameters normally used by most authors to
characterize the reliability of the cough stress test include
sensitivity, specificity, positive predictive value, and negative
predictive value [31–35]. Sensitivity and specificity are the
most common parameters for the comparison of clinical tests
[32], being independent of the prevalence of the disease in
the study population. Scotti and Myers [29] have shown that
simple cystometry combined with a cough stress test is
highly reliable in making the diagnosis of genuine stress
incontinence. Wall et al. [30] have shown that bladder filling
without pressure measurement, combined with a cough
stress test is a simple, inexpensive, and reliable way of
selecting patients with urge incontinence related to detrusor
overactivity from those patients with straightforward stress
urinary incontinence. According to Swift and Ostergard [28],
the cough stress remains a highly specific test, particularly
when combined with a prior negative cystometrogram.
Description of the cough test
If stress urinary incontinence is suspected, a provocative
stress testing with direct visualization can be performed.
The patient is asked to relax and cough vigorously while
the examiner observes for urine loss from the urethra [36].
Optimally, this test should be performed when the patient’s
bladder is full. The stress test, also known as cough stress
test [37] or provocative stress test [36], is a simple test that
involves filling a patient’s bladder to at least 300 ml or
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symptomatic fullness. Bladder filling for stress testing may
be performed conveniently in conjunction with catheteriza-
tion for post-void residual (PVR) measurement [36]. A non-
catheterized cough test can be performed after instructing
the patient to urinate 2 h before the test, followed by
drinking two cups of water (16 oz). The bladder volume is
checked with the bladder scan, and if the volume is
between 250 and 300 cc, the test is performed. The patient
is asked to cough while standing, usually on a blue towel,
with her legs apart (or in the supine position if she is unable
to stand), and the physician directly visualizes the urethral
meatus. If urine leaks from the external urethral meatus, the
result is a positive cough stress test. If the test is initially
performed in the supine position and no leakage is
observed, then the test is repeated in the standing position
[36]. It has been observed that some patients do not cough
forcibly in the laboratory setting and may consciously hold
in during the test; thus, it is important that the patient relax
before being asked to cough vigorously [36].
The cough stress test can also be performed with the
bladder empty, known as the supine empty stress test
(SEST). Generally, the patient voids first before the pelvic
examination and is asked to cough or perform a Valsalva
maneuver while in the lithotomy position. If the patient
loses urine, she has a positive SEST [37]. Using maximal
urethral closure pressure to diagnose ISD, Lobel and Sand
[33] reported that the SEST had 65 to 70% sensitivity and
67 to 76% specificity for predicting ISD. Interpretation of
the results after testing for urinary incontinence can be
summarized in the Table 1 [36, 37].
Using abdominal leak point pressure (ALPP) to define
ISD, McLennan and Bent [31] reported that SEST had 79%
sensitivity and 63% specificity. Conversely, Hsu et al. [32]
reported that the SEST had 93.5% sensitivity, 90%
specificity, 96.7% positive predictive value, and 81.8%
negative predictive value for detecting ISD. The residual
urine volume at the time of the test does not significantly
affect the diagnostic accuracy of SEST for the prediction of
low Valsalva leak point pressure (VLPP) [34]. The overall
sensitivity and positive predictive value of the SEST,
regardless of the residual volume, is insufficient to make a
diagnosis of low VLPP without multichannel urodynamics.
The standardization principle used by Hsu et al. [32], to
perform the supine stress test and bladder filling to 200 ml,
avoids potential confounding factors such as significant
PVR, use of diuretics, or presence of polydipsia noted in
other studies.
Clinical use
Some published studies seem to indicate that performing a
cough stress test before filling the bladder can be unreliable
and may miss 80% of the cases of stress incontinence, but
when performed at a bladder volume of 300 ml or
symptomatic fullness, the test is highly reliable [27, 29, 37].
A positive cough stress indicates a good correlation with the
presence of stress urinary incontinence; however, if uninhib-
ited detrusor contractions are noted during a cystometro-
gram, preceding the cough stress test, the results become
suspect [27, 35, 37], and the diagnosis of stress incontinence
should be confirmed by multichannel studies [28]. A
negative cough stress test rules out most cases of stress
incontinence [35]. If a cough stress test with bladder filling is
used more frequently in the initial evaluation of incontinent
women, some authors believe that practitioners, with limited
access to sophisticated urodynamic studies, will be able to
select patients for further testing in a more informed way
[30]. Thus, the available evidence demonstrates that the
cough stress test can be a useful and reliable tool in the
diagnosis of SUI. However, for a more complete evaluation,
it must be used in conjunction with other urodynamic
testing, particularly if detrusor overactivity is suspected. The
cystometrogram and cough stress test are not essential for a
basic evaluation, particularly if a conservative therapy is
contemplated; however, if a more invasive treatment is
needed, these tests should be performed [37].
The diagnostic accuracy of the SEST was found to be
poor for prediction or exclusion of low maximum urethral
closure pressure [31, 33]; however, this test has been shown
to have a negative predictive value of 90% for ruling out a
low VLPP in a referral population [31]. Thus, this simple
test has been recommended as a means for the urogyneco-
logic surgeon to be reasonably assured that ISD is not
present, without performing multichannel urodynamics
before stress incontinence surgery [31, 33, 34].
Lobel and Sand [33] performed the SEST at a variable
interval up to 20 min after bladder catheterization.
Conversely, McLennan and Bent [31] performed the SEST
without uniformly catheterizing patients to ensure bladder
emptiness. It is noteworthy to find that data on patient age,
parity, prior gynecological surgery, and prior incontinence
surgery did not significantly improve the predictive value
of the supine stress test for ISD [32].
The SEST is easy to perform, inexpensive, and without
significant risk. A positive SEST in combination with a fixed
urethra is diagnostic for ISD. In low prevalence populations,
Table 1 Results after testing for urinary incontinence
Test Result
No leakage with cough stress test Negative
Instantaneous leakage with cough stress test Positive
Leakage in spurts on cough stress test Positive (mixed)
Delayed leakage with flow Detrusor overactivity
Leakage with empty bladder, supine position ISD [5, 10]
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a negative test reliably excludes the presence of ISD.
However, for high prevalence and referral populations, the
low predictive values of the test limit its usefulness.
Conclusions and recommendations
The cough stress test, according to a body of evidence
consisting of randomized controlled trials, appears to be a
reliable and simple test for the diagnosis of stress urinary
incontinence. It should be viewed only as a screening test
requiring further evaluation with more sophisticated urody-
namic tests. The supine empty stress test is the most reliable
non-urodynamic predictor of ISD. The cough stress test is
recommended for both clinical research and practice.
The empty supine stress test is optional for both.
Incontinence severity and evaluation
Mitesh H. Parekh, Karl Tamussino
Severity of incontinence
It is often useful, both in a clinical setting or for research
purposes, to make an assessment of the severity of
incontinence. In a clinical setting, assessing severity helps
to determine which patients need care and to evaluate the
effectiveness of care rendered. In a research setting, we need
reliable instruments that will accurately differentiate change
in incontinence severity to evaluate and compare treatments.
Different instruments have been described to assess the
severity of incontinence. These instruments can be classified
into subjective or objective measures and further divided by
whether they are validated instruments or not.
Subjective measures
Not validated
A voiding diary is the simplest method utilized to quantify
urine loss. The period recorded in a voiding diary varies. A 1-
week diary has been shown to reliably assess the frequency
and estimated amount of urine loss [38]. Elser et al. [39]
found a significant correlation between the number of
incontinence episodes recorded in the diary and patient
history. For obvious reasons, it can be a subjective and crude
method. As described in the previous chapter on Voiding
diaries, the 3-day diary correlates well with the 7-day diary
and is recommended for use in clinical research and practice.
Visual analog graded scale responses, such as the 10-cm
analog scales, have been used. Frazer et al. [40] found that
such scales correlated poorly with more standardized
measures such as the 2-h pad test.
Stamey’s incontinence scoring system (Table 2) is based
on the patient’s incontinence history alone and is similar to
a classification used earlier by Ingelman-Sundberg [41]. It
has not been validated but is simple and has been used
frequently in research to measure outcome, especially with
injectable bulking agents.
Various methods of estimating severity of leakage based
on questions related to frequency and amount of leakage
have been described [42]. Other authors have estimated
severity of leakage based on activity restriction, extra
laundry, pad usage, and wet clothes [43, 44]. None of the
above methods were validated, nor were they objective due
to multiple biases that may interfere with the assessment.
Validated
The Urogenital Distress Inventory (UDI) for Women [45] is
a symptom inventory instrument for assessing disease
severity. A validated short form correlates well with the
long form and is also available for use in practice (see
chapter on QOL measures)[46].
The Severity Index for Urinary Incontinence in Women
[47, 48] is a simple severity index for urinary incontinence
in women (Table 3). It can be used to initially evaluate a
patient and to monitor the response to interventions.
The index value obtained by multiplying the total amounts
in the two parameters is further characterized into a severity
index of three or four levels. The score range is then a
minimum score of 0 to a maximum score of 8 (or 12 for the
fourth level). The higher the score, the more severe the urinary
incontinence. Sandvik’s index is a valid representation of
severity as measured by the pad weighing test [48].
The Leakage Index for Women with Urinary Stress
Incontinence is a five-point scale containing 13 types of
exertions [49]. The leakage index was found to be
reproducible, but a limitation is its design for use in women
with stress incontinence only.
Objective measures: pad testing
Pad testing denotes a validated methodology to quantify
urine loss by measuring the weight gain of absorbent pads
during a test period [50]. Pad testing can quantify urine loss
Table 2 Stamey’s incontinence scoring system
Grade 0 No incontinence
Grade 1 Incontinence with coughing or straining
Grade 2 Incontinence with change in position or walking
Grade 3 Total incontinence at all times
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but provides no clue as to the mechanism underlying the
urine loss. Many pad tests have been described. Short-term
(<1, 1, 2 h) and long-term (24 h and longer) tests have been
used. Short-term tests are done in the office setting; longer
tests are done by the patient in her daily environment. The
International Continence Society (ICS) endorsed a 1-h pad
test [51], which was however subsequently shown to have
poor interdepartmental correlation and to be highly depen-
dent on bladder volume [50].
Longer duration pad tests seem to be more reliable and
accurate [52], but patient adherence and tolerance will be
better in shorter tests; they are obviously cheaper and easier
to conduct. In at least one study, the 1-h test had nearly
100% correlation with a 12-h test. There are also other
studies that show reproducibility and reliability of the
1-h test. The ICS has standardized the 1-h test for research
purposes, as with longer tests, the investigator has no
control over the test [38]. The ICI recommends a 20-min to
1-h test at standard bladder volume or 24-h at-home test,
and it rates the level of evidence at 3 and grade of
recommendation at C for both [53]. The 1-h test will have a
higher false negative rate when leakage is mild or when
patients are having OAB wet, which cannot be reproduced
reliably during the 1-h test.
Pad tests can quantify urine loss with a fair degree of
reliability but provide no information on the mechanism
underlying leakage
– 1-h pad testing
– Not very accurate unless a fixed bladder volume is
used
– Set exercises during the test improve test–retest re-
liability, sequence of tests has little effect on test results
– A pad weight gain ≥1 g suggests a positive 1-h test
– –24-h pad testing
– Not standardized
– Correlates well with symptoms of incontinence
– A 24-h test has good reproducibility but poorer
compliance than a 1-h test
– A pad weight gain ≥1.3 g = positive 24-h test (The
upper limit of normal increase in pad weight varies
according to the characteristics of the pad used.
Highly absorbent pads will weigh up to 5 g)
– A test lasting longer than 24 h has little advantage.
Many studies on incontinence use higher values for pad
weight test, depending on the type and characteristics of the
pad. In a 1-h test, more than 2 g was used, and in the 24-h test,
more than 8 g are indicators for incontinence.
Conclusions and recommendations
Pad tests have the advantage of directly measuring the
amount of urine loss. They are inexpensive, noninvasive,
and quite simple. As they do require active participation
of patients for a prolonged period, accuracy may come at
the cost of non-adherence. Many versions of pad tests
are available; a longer version might be more useful in a
research setting to increase the accuracy, and the short
version, such as the standardized 1-h ICS pad, is test more
practical. Sandvik’s severity index may be an acceptable
alternative to pad testing, especially in large epidemiolog-
ical studies where pad testing might be cumbersome.
Pad testing is recommended for clinical studies, and
optional in practice. Both 1 and 24-h pad tests are suitable
for stress urinary incontinence. The 1-h pad test is not
recommended for urge incontinence. Measurement of
incontinence severity is recommended for research and
optional in clinical practice.
Quality of life measures
Roger Goldberg
A basic challenge in studying and treating prolapse and
incontinence lies in the largely subjective nature of these
conditions. Their true impact is not solely based on
discriminate variables but rather on the composite effect of
numerous factors on a patient’s overall lifestyle. For instance,
daily voiding episodes or pad weight may not reveal the full
impact of a therapeutic intervention on a patient’s ability to
resume, and enjoy, a normal routine. Focus groups have
demonstrated that clinicians and patients may indeed view the
impact of incontinence on quality of life differently, with
Table 3 Severity index for urinary incontinence in women [47, 48]
Parameter Finding Points
How often is urine leakage
experienced?
Never 0
Less than once a
month
1
1 to several
times a month
2
1 to several
times a week
3
Every day and/or
night
4
How much urine lost each time? A few drops 1
A little 2
More 3
Severity index=(points for frequency)×
(points for amount)
1–2 = slight, 3–6 = moderate, 8–9 =
severe, 12 = very severe
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patients focusing more on emotional well-being and disrup-
tion of routine activities [54]. When considered alone, neither
urodynamic parameters nor symptom severity can reliably
predict the quality of life impact of incontinence [55]. In
assessing surgical outcomes, urogynecologists should there-
fore recognize that changes to objective measures, such as
incontinence episodes, may fail to reflect changes—for
better or worse—to the patient’s actual quality of life.
A number of validated health-related quality of life instru-
ments, falling into two major categories—general and
condition-specific—have emerged over the past several years.
Health-related quality of life
Health-related quality of life (HRQOL) is a composite health
care outcome implying several subsets of function, often
categorized into physical well-being, social function, mental
health, societal role, and general health perception. HRQOL
instruments are typically comprised of numerous patient-
completed questions, or items, arranged into several domains.
In evaluating the impact of urogynecologic conditions
on HRQOL, it becomes clear that these disorders can
negatively impact all QOL domains. Patients with inconti-
nence suffer a constellation of symptoms often leaving
them uncomfortable, embarrassed and socially withdrawn.
Self-esteem and body image may be profoundly altered by
wetness, skin irritation, and odor, or the need for absorbent
products. One study found that incontinent women spend
less time walking, communicating with friends and family,
working for pay, and engaging in personal grooming and
hygiene then similar continent women [56]. Indeed, for
many individuals, incontinence may be viewed as a sign of
one’s lost independence and lack of self control. Further-
more, many patients begin to adopt alternative coping
strategies which include restricting one’s wardrobe to dark
clothing to hide urine stains, avoidance of sexual intimacy,
reduction of oral fluid intake, and bathroom “mapping”
[57]. In the elderly, QOL implications can become even
more profound as incontinence becomes a common reason
underlying nursing home admission [58]. The U.S. Special
Committee on Aging has identified incontinence as one of
the top QOL issues affecting the elderly.
Recommended tools
Determining the “best” measure of QOL impact remains a
work in progress, largely because urogynecological con-
ditions are associated with variable effects on psychologi-
cal, physical, and sexual health. Cultural differences may
also markedly influence the degree of bother experienced
and/or reported by individual patients. QOL questionnaires
in this field vary substantially in their content and in their
specificity for incontinence.
Most patient-completed questionnaires consist of several
domains. Examples may include “role limitations”, “social
limitations”, “physical limitations”, “general health percep-
tion”, “emotional impact”, “sleep and energy”, and effects
on personal relationships. Differences between question-
naires include the degree of condition-specificity (i.e.,
targeting QOL issues relating to only incontinence, vs
those applicable to multiple health conditions), the period
of time the patient is asked to report on, and the population
wherein the test was validated. Both general and condition-
specific HRQOL questionnaires may reveal important
aspects of the patient’s subjective experience before and
after treatment. It is important to recognize that medical
comorbidities may alter the scoring of both general and
condition-specific questionnaires [59] and should be con-
sidered when comparing scores across populations.
General instruments
One disadvantage of nonspecific surveys is their limited
ability to characterize impairments specific to incontinence
or pelvic floor dysfunction and their limited sensitivity for
detecting small to moderate differences in QOL stemming
from pelvic and (LUTS).
SF-36 is the most common general HRQOL instrument,
a self-administered tool organizing HRQOL into eight
scales addressing physical function, social function, pain,
emotional well-being, energy, general health perceptions,
and role limitation due to physical and/or emotional
problems [60]. Two subscales—physical and mental—
may also be separately totaled. Kutner, et al. [61] found
the SF-36 performed acceptably among incontinent
patients. The SF-36 has been used to demonstrate dimin-
ished quality of life across numerous domains (including
physical function, role function, bodily pain, health percep-
tions, social functioning, and mental health) for subjects
with both ‘wet’ and ‘dry’ OAB [62]. Because the SF-36 is
not specific to incontinence, it is particularly well suited for
making comparisons across conditions—in other words,
comparing the relative QOL impact of incontinence to
hypertension, diabetes, and other unrelated disease states
[63]. A general survey such as SF-36 may also be
successfully used for demonstrating HRQOL differences
between continent and incontinent subjects. In one such
study, Hagglund et al. [64] demonstrated that incontinent
women reported significantly lower scores in all eight
domains of the SF-36 and that urge had a greater impact
than stress incontinence.
Oh, et al. compared the SF-36 to an incontinence-specific
questionnaire in 109 stress incontinent women and 80
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controls and concluded that the generic instrument had poor
sensitivity for estimating the incontinence impact on QOL
(65). However, as already mentioned, in appropriate settings,
they offer the flexibility of comparing the broad impact of
prolapse, incontinence, or any other specific condition to
unrelated medical states.
Disease-specific instruments
Several HRQOL questionnaires have been introduced in the
urogynecologic community in recent years and are tailored
specifically for women with urinary, colorectal, and sexual
disorders, and become increasingly specific for detecting
change within samples of women affected by those
disorders. The majority of incontinence-specific QOL
instruments are available in the public domain. Two of the
most common are the Incontinence Impact Questionnaire
(IIQ) and the Urogenital Distress Inventory (UDI), both of
which were designed specifically for incontinence in the
female population. Short-form versions (IIQ-7, UDI-6) of
the original questionnaires are useful for clinical practice,
where the original 53-item version may prove to be
excessive. IIQ-7 and UDI-6 scores have been shown to
significantly change after surgery for stress incontinence,
and POP, with subjective continence after surgery, is
associated with superior scores on both scales [66]. The
IIQ and its short form (IIQ-7) have taken on increasing
popularity in epidemiological surveys and clinical trials,
more commonly used in the context of stress urinary
incontinence but also providing a valid QOL instrument
within urge-incontinent samples [67, 68].
The Pelvic Floor Distress Inventory (PFDI) and Pelvic
Floor Impact Questionnaire (PFIQ) represent expanded
modifications of the UDI and IIQ, respectively. They
incorporate a broader array of pelvic floor questions. The
PFDI assesses patient perception of distress relating to three
clinical domains—urinary incontinence, colorectal dysfunc-
tion, and pelvic organ prolapse. The PFIQ estimates life
impact across the same clinical domains. The sheer size of
these questionnaires (PFDI 61 items, PFIQ 93 items) may
reduce their utility within most clinical settings. Short-form
versions of these surveys (PFDI-20 and PFIQ-7) were, as a
result, recently introduced—and have been demonstrated to
be valid and reliable in women with pelvic floor disorders
[69].
The King’s Health Questionnaire (KHQ) is a 21-item
measure of HRQOL, designed for incontinent women [70].
The KHQ correlates reliably with the SF-36, it has been
well established as reliable and valid among subjects with
OAB [71], and it has been used to demonstrate subjective
benefit among incontinent subjects receiving therapy [72,
73]. The KHQ has been translated into multiple languages.
Wren, et al. [74] established the reliability of a composite
condition-specific QOL measure in women undergoing
surgical treatment for pelvic organ prolapse and stress
urinary incontinence, using a telephone-based QOL ques-
tionnaire. The questionnaire drew from several validated
general and condition-specific HRQOL instruments (MESA,
Hunskaar severity measure, PFDI, PFIQ, PISQ, SF-36 and
LOT-R). Interviews were completed on 88 women,
approximately 1 year after pelvic reconstructive surgery
and then were repeated on each participant 2 weeks later to
establish reliability of the telephone interview-based QOL
assessment.
Other disease-specific instruments include the Symptom
Severity Index (SSI) and Symptom Impact Index (SII).
These short questionnaires (eight questions) were devel-
oped within a sample of women having stress incontinence
surgery. There is little data to indicate their ability to
respond to changes after therapeutic intervention.
OAB and quality of life
In measuring quality of life before and after pelvic
reconstructive and incontinence surgery, one cannot over-
look the potential role of OAB. Several studies have
demonstrated that patients with urge incontinence report
more emotional disturbance and lower HRQOL then
patients with stress incontinence [75] and rate their need
for medical attention as significantly higher [76]. According
to the Social Function Questionnaire (SF-36), individuals
with OAB demonstrate diminished capacity in most of the
survey subsets addressing social and functional capabilities,
even lower than other chronic diseases such as diabetes and
hypertension [77]. Modified versions of the IIQ and UDI
(the U-IIQ and U-UDI) have been developed to characterize
the quality of life impact of frequency, urgency, and urge
urinary incontinence, in more detailed fashion. To date, the
only questionnaire specifically developed and validated for
the evaluation of HRQOL in OAB patients (both “wet” and
“dry”) is the OAB-q [78, 79].
OAB and incontinence are also associated with adverse
effects on sexual function [80]. In addition, and perhaps not
surprisingly, OAB has been associated with depression—
likely due to the diminished self-esteem, feelings of
helplessness or shame, social withdrawal, and reduction in
physical fitness that accompany this disease [81, 82]. A
study of 115 community-dwelling incontinent patients
demonstrated that 60% suffering from urge incontinence
had concurrent symptoms of depression according to the
Beck Depression Inventory [83].
Other QOL instruments validated within incontinent
populations, and applicable for the assessment of OAB,
include the Incontinence Impact Questionnaire (IIQ) [45],
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Urge Impact Scale (URIS), I-QoL [84], and York Inconti-
nence Perceptions Scale (YIPS) [85].
Sexual dysfunction after surgery for SUI
Reporting urinary incontinence to a health care profes-
sional by patients is difficult because of its stigma.
Female sexual dysfunction (FSD), when co-existing with
urinary incontinence, is usually not reported by patients
and not explored by physicians. Barriers to screening for
FSD exist, most commonly due to “lack of time” and
unsatisfactory training with respect to FSD [86]. When
sexually active women complete sexuality questionnaires,
pelvic floor dysfunction (PFD) does not appear to
independently affect sexual activity or satisfaction
(86,87). On the contrary, patients with UI may have a
low sexual desire, related to a long history of stress urinary
incontinence (SUI) and the fear of having an episode of
urinary incontinence (UI) during intimacy, thus, resulting
in sexual anxiety [88].
For patients with SUI who are going to be treated with
surgery, coital UI after surgery for SUI was less acceptable
than having postoperative frequent small leaks [89].
Because sexual activity and sexual satisfaction are very
important aspects for patient’s quality of life, and may be
affected by surgical treatment of SUI, we have to consider
both as an outcome measure of this surgery. Conflicting
sexual function outcome results have been reported after
SUI surgery. In general, most of the studies reported
reduction in episodes of coital incontinence postoperatively
with overall improved sexual function. Some studies found
a few cases of postoperative “de novo” dyspareunia or
anorgasmia [90, 91]. To evaluate if there is a sexual
dysfunction, it is very important to have an instrument to
measure the level of personal distress related to the sexual
problems identified [92].
How to measure the changes with surgical treatment
of SUI
A few studies have measured the changes in sexual life
before and after surgery by validated questionnaires. The
most frequently-used questionnaires in urogynecological
patients have been the Female Sexual Function Index
(FSFI) and the Pelvic Organ Prolapse/Urinary Incontinence
Sexual Questionnaire (PISQ) specific for UI/POP (long or
short form, PISQ-12). In published studies, which utilized
these two questionnaires, the total score is better postoper-
atively, with improvements in both the physical and
partner-related domains but no improvement in behavior
emotive domains [(93, 94].
In clinical practice, it is not always easy to use these
questionnaires most commonly due to lack of time. In
addition, cultural and religion aspects may influence a poor
response rate.
There is a need to develop new instruments that can be
used in clinical practice and in different cultural contexts, to
investigate sexual activity and related symptoms that can be
directly related with urogynecological problems and as
outcome measures for the impact of the treatments. FSFI
and PISQ are very useful instruments for research (recom-
mended); however, a shorter patient-friendly tool for clinical
practice is not yet available (optional).
Effect of treatment on HRQOL
For patients undergoing prolapse or incontinence surgery,
meaningful data on HRQOL can be reliably collected pre-
and post-procedure. An increasing number of studies are
evaluating the response of validated HRQOL instruments to
therapeutic interventions for incontinence and pelvic floor
dysfunction, however in comparison to studies focused on
anatomic and physiological outcomes, relatively few have
been published to date.
Conclusions and recommendations
Standardized QOL questionnaires are increasingly recog-
nized as an important, and in many cases, necessary
measure by which to judge the success of therapy. Some
(e.g., PFDI) are especially useful for patients with concur-
rent prolapse or colorectal complaints. General question-
naires are more suitable for research than clinical practice,
due to limited sensitivity in detecting clinically meaningful
QOL changes.
General instruments are optional in clinical research
studies and not recommended in practice. Incontinence-
specific questionnaires, especially short-forms are recom-
mended for clinical studies, and optional for clinical practice.
Urethral mobility
Chahin Achtari
Introduction
The definition of stress urinary incontinence (SUI) involves
involuntary loss of urine caused by physical exertion such
as coughing and/or sneezing leading to an elevation of the
intra-abdominal pressure. The pathophysiology of this
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condition is a variable combination of urethral hypermo-
bility and urethral sphincter deficiency. A certain degree of
mobility is considered as normal and even necessary for the
normal function of the urethra. In the resting position, the
proximal urethra is maintained in a high retropubic position
within the intra-abdominal pressure compartment like the
rest of the bladder. The distal third of the urethra is fixed to
the pubic bone through the perineal membrane, whereas the
proximal urethra is mobile. The endopelvic fascia is a layer
of connective tissue covering the ventral aspect of the
levator ani muscle and is responsible for the support of
pelvic organs. The periurethral endopelvic fascia connects
the proximal part of the urethra to the arcus tendineus fascia
pelvis and to the levator ani muscle. Urethral mobility
depends on the muscular activity of the levator ani muscle,
which is maintained within a certain limit by the fascial
attachment. In the resting position, levator muscle tonic
activity maintains the high retropubic position, and relax-
ation of the levator before micturition provokes a straight-
ening of the posterior vesico-urethral angle and an opening
of the urethra.
Urethral hypermobility is caused by a defect in the
connective tissue that normally supports the urethra and
anchors it to the surrounding structures or to muscular
defect. It is widely accepted that urethral hypermobility is
associated with SUI although this association is not
systematic. In fact, there is no accepted definition of
urethral hypermobility, as a certain degree of urethral
sphincter incompetence is often associated leading to a
wide overlap between normal and pathologic urethral
mobility. Several tests are available to demonstrate the
degree of urethral mobility, some of which allow direct
visualization of the urethra and some that are indirect tests.
Cotton-tipped swab test
The cotton-tipped swab test (Q-tip) is an indirect clinical
test evaluating the angle between a cotton swab introduced
at the level of the bladder neck and the horizontal plane at
rest and during a Valsalva maneuver. This test was initially
described in 1971 [95] and subsequently standardized by
Karram et al [96]. In the initial description, Crystle et al.
found that patients with good urethral support had a
rotation angle of less than 20° so that an excursion of 30°
or more is generally regarded as bladder neck hypermobil-
ity. However, there is still a great variation in the way the
test is performed, especially in the positioning of the patient
and location of the cotton swab end.
The Q-tip test is inexpensive, simple, and easy to
perform. It has therefore been widely utilized in studies to
evaluate urethral mobility before and after SUI surgery or
childbirth.
Karram and Bhatia [96] standardized performance of the
Q-tip test. They demonstrated that the tip of the swab
should be placed in the proximal urethra or urethra–vesical
junction (UV), that the degree of bladder filling had no
significant influence on the result, and that the result should
be expressed in “maximal straining angle” instead of
“positive/negative”. In patients with anterior vaginal wall
relaxation, there is no significant difference between the
continent and incontinent groups, both being superior to
30°. In another study, Pollak et al. [97] found that the
straining angle was altered, with a lesser maximal straining
angle with the prolapse reduced. Also, it has been
demonstrated that the position of the patient had an impact
on proximal urethral mobility with an increased mobility in
the supine over the standing position [98].
However, the Q-tip test is not a diagnostic test for SUI.
In patients with SUI, the test is positive (i.e. >30°) in 90%,
but it is also positive in about 30% of patients with bladder
instability and in 50% with pelvic organ prolapse without
stress incontinence. Although it was initially found to have
a good correlation with bead chain cystourethrography, it
has been criticized by Caputo and Benson who found poor
correlation between UVJ mobility measured by ultrasound
and a Q-tip test [99].
The Q-tip test should be performed in a standardized
fashion, with the patient in lithotomy position, a well-
lubricated cotton-tipped swab is introduced into the urethra
to the bladder. Gently withdraw until resistance is met,
indicate the bladder neck position at the urethrovesical
angle. Resting and straining angles are measured from the
horizontal. A straining angle of >30° is a positive test for
urethral hypermobility.
Perineal sonography
Ultrasound is a noninvasive, readily available, radiation-
free and is easy test to perform. Perineal ultrasound is
performed with a 3.5- to 5-MHz curved probe placed on the
perineum, usually between the labia to enhance the
visualization of pelvic organs. It allows direct visualization
of the urethra, UVJ, and bladder. The fixed landmark that is
usually used to measure the position and mobility of the
UVJ is the symphysis pubis. Schaer et al. [100] described a
method to measure bladder neck position in a two-
dimensional axis system, where the X axis is a line passing
through the central part of the symphysis pubis, and the Y
axis is perpendicular at the level of the lower border of the
symphysis. Dietz [101] recommended use of a horizontal
line at the inferoposterior margin of the symphysis as a
landmark. With either method, it is easy to measure bladder
neck position at rest and during Valsalva maneuver, bladder
neck descent, and the posterior urethrovesical angle. It is
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also possible to have qualitative information about the
bladder neck such as the presence of a funneling and
sometimes visualization of urine passing in the proximal
urethra.
Some parameters affect the measurement results, so the
test should be performed in a standardized fashion [102].
Although bladder filling has little impact on bladder neck
position, UVJ mobility is affected [103], so the test should
be performed at a standardized bladder volume, such as
300 ml. Patient position and probe pressure on the
perineum also affects bladder neck position, and it is
recommended to perform the test in the supine position
with low pressure on the perineum.
Unfortunately, there is no sonographic definition of UVJ
hypermobility. Several studies looked at UVJ mobility in
continent and stress incontinent patients [103, 104]. During
Valsalva, the UVJ is displaced backwards and downwards
in a rotational movement. Mobility can therefore be
measured as a linear displacement, a descent, or a change
in angle between two axes. Dietz and Wilson [103] showed
that bladder neck descent of more than 25 mm and a
retrovesical angle of 165° were strongly associated with
stress incontinence. Conversely, Peschers et al. [104]
showed that the bladder neck can be mobile up to 32 mm
in continent nulliparous patients. It would therefore be very
useful to find a cutoff limit, above which we can speak
about hypermobility even if it is not associated with stress
incontinence. Until then, we can only be descriptive and
report the measured mobility of the urethra. Perineosonog-
raphy is optional in clinical trials and optional in clinical
practice in patients with proven SUI to evaluate urethral
mobility.
Videocystourethrography
Videocystourethrography (VCU) is a radiologic test allow-
ing direct visualization of the bladder, urethra, and UVJ
through a contrast medium instilled into the bladder.
Urethral mobility can be appreciated on lateral views,
although bony structures may impair the quality of images
that can be improved by digital subtraction imaging. VCU
has long been considered as the “gold standard” to
investigate LUT dysfunction, as it can be combined with
urodynamics.
The position of the bladder neck and the different angles
can be measured to evaluate UVJ mobility. As with
ultrasound, the posterior urethrovesical (PUV) angle can
be measured between the two lines passing along the
posterior urethra and the bladder base and should be 115°
or more. VCU allows visualization of the voiding phase,
thus calculation of the urethropelvic angle. The distance
between the internal urethral orifice and the symphysis
(SO) can also be measured and should not be less than
20 mm. Correlation between VCU and perineal ultrasound
has been found to be good for urethral mobility and PUV
and SO [105]. VCU is optional for the evaluation of
urethral mobility in clinical trials and not recommended in
clinical practice, as it requires special facilities that are not
available in all units, and it exposes patients to radiation.
Conclusions and recommendations
In conclusion, urethral mobility is an important aspect of
the evaluation of SUI. An effort should be made by
investigators and research committees to define urethral
hypermobility and standardize the different techniques that
should be performed before and after surgery for stress
incontinence. Urethral hypermobility is diagnosed in
virtually 100% of all cases of grades II–IV prolapse.
Urethral mobility assessment by Q-tip test (and/or
optional perineal ultrasound) is recommended for both
clinical research and practice in stages 0 and I. It is optional
in stages >I.
Q-tip test is optional for both clinical research and
practice to assess urethral mobility. Perineal ultrasound is
optional in research and clinical practice.
Pelvic organ prolapse assessment
Chahin Achtari
Introduction
The pelvic organ prolapse quantification (POPQ) system
was introduced in 1995 to standardize the evaluation of
pelvic organ prolapse. A document was published describ-
ing the POPQ, which was subsequently reviewed and
adopted by the membership of the International Continence
Society, American Urogynecologic Society, and the Society
of Gynecologic Surgeons. The POPQ classification system
is unique, in that it is the only system that has undergone
extensive testing in several studies to validate its use as a
tool to describe and study pelvic organ prolapse [106–110].
It requires measurement of the distance between six defined
points within the vagina and the hymeneal ring. The
position of each point will define the prolapse stage. The
first defined point is point Aa which is situated 3 cm
proximal to the external urethral meatus and roughly
corresponds to the urethro-vesical junction (UVJ). Stages
are assigned according to the most severe portion of the
prolapse when the full extent of the protrusion has been
demonstrated. However, a stage can be defined for each
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point: stage 0: no prolapse is demonstrated; stage I: the
most distal portion of the prolapse is >1 cm above the level
of the hymen; stage II: the most distal portion of the
prolapse is <1 cm distal to the plane of the hymen; stage III:
the most distal portion of the prolapse is >1 cm below the
plane of the hymen, stage IV: complete eversion of the total
length of the lower genital tract. This system has an
excellent inter- and intra-observer correlation and allows
comparison within and between patients. It can therefore be
expected that a precise measurement of the position of point
Aa can be correlated with UVJ position and mobility.
Montella et al. [111] measured the descent of the
urethro-vesical crease (point Aa) and compared it to the
Q-tip test to evaluate proximal urethral support in 111
patients complaining of prolapse and/or urinary inconti-
nence; 83 patients (75%) had a positive Q-tip test (≥30°).
Descent of point Aa to −2 cm from the hymen provided a
good sensitivity of 94% but poor specificity (36%). The
optimal cutoff point was −1 cm with a sensitivity of 67%
and specificity of 61%. There was a significant relationship
between a positive Q-tip test and cutoff point ranging from
−2 to +1 cm (P<0.05). At +2 or +3 cm, the positive
predictive value was 100%.
A similar study was performed by Cogan et al. [112] on
274 patients with urinary incontinence or pelvic organ
prolapse. A correlation was calculated between points Aa
and Ba and the Q-tip test. Although they found a
moderately strong correlation between point Aa and Q-tip
straining angle, with r=0.47 (P<0.001), one could not
predict the other. However, at stages II, III, and IV for point
Aa, urethral hypermobility is present in virtually 100% of
patients.
Noblett et al. [113] confirmed that in stages II–IV,
urethral hypermobility was found in 100% of cases.
However, they found only 6% of patients at stage 0 for
point Aa with hypermobility; at stage I, hypermobility was
demonstrated in 91% with straining angles of 37.6±9.3°.
All studies agree that in stages II–IV for point Aa, the
likelihood of finding urethral hypermobility is virtually 100%.
Therefore, the Q-tip test may not be necessary in these
patients. In patients with stages 0–I, the positive predictive
value is 82%, and the negative predictive value is 94%.
Pop and stress incontinence
As 10–40% of women with stress incontinence have a well-
supported urethra and inversely, 50% of continent women
have urethral hypermobility as measured by the Q-tip test,
Tapp et al. [114] studied the predictive value of point Aa and
the Q-tip test to diagnose urodynamic stress incontinence.
They compared 352 women with a diagnosis of urodynamic
stress incontinence (USI) and 245 control cases. Point Aa
was not associated with USI; in fact, an increasing Aa value
was associated with reduced risk of USI, whereas the odds-
ratio of having stress incontinence with a positive Q-tip test
was 3.10. The sensitivity of the cotton-tipped swab test for
predicting stress incontinence was 80%, with a specificity of
42%, negative predictive value of 59%, and positive
predictive value of 67%. The Aa point had a sensitivity of
37%, specificity of 58%, negative predictive value of 39%,
and positive predictive value of 56%.
Among patients presenting with stress incontinence, Bai
et al. [115] found 63.6% of coexisting prolapse (19/30).
The majority (53.3%) of these patients had stage II (16 of
30), and 50% had a point Aa substage for prolapse.
Conversely, in patients presenting for greater than grade II
pelvic organ prolapse, 62.6% had coexisting stress incon-
tinence, with 52.2% having type II incontinence, yet half of
the patients complaining only of mild incontinence.
When looking at clinical factors associated with severity
of stress incontinence, Richter et al. found a negative
correlation between increasing stage of prolapse measured
by the POP-Q and severity of incontinence in patients with
a POP-Q stages 0–II, showing twice as many episodes of
incontinence compared to stages III/IV [116].
Conclusions and recommendations
In conclusion, POP-Q is useful for pelvic organ prolapse
grading, but descent of point Aa is not a reliable method to
quantify urethral mobility and has no correlation with stress
incontinence. The only correlation is a negative one, so that
a stage 0 or I for point Aa is associated with more severe
incontinence. Prolapse assessment using POPQ is recom-
mended for research and optional for clinical practice.
Simplified POPQ or simple staging is recommended for
clinical practice. POPQ-Aa is not recommended for
urethral hypermobility diagnosis.
Patient satisfaction
Kimberly Kenton, Roger Goldberg
Over the last several decades, patient expectations and
satisfaction for surgical treatment have gained increasing
attention, forcing surgeons to reevaluate traditionally used
outcome measures. Patient satisfaction after medical treat-
ment is primarily determined by patient expectations [117–
119]. Early research on patient expectations focused not on
the patient’s expectations, but on those of the primary care
physician. However, differences between patient and
physician perceptions of outcomes and satisfaction are
becoming apparent throughout medicine [120]. Time-
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honored objective outcome measures used by physicians
are no longer satisfactory for determining surgical success.
Focus is increasingly shifting to the role of patient expect-
ations and quality of life in determining the success of
surgical treatments [121, 122].
Several validated general health and condition-specific
quality of life measures (QOL) have been previously
discussed. While these measures are essential components
of outcome assessments, they are typically long and do not
always relate the patient’s overall clinical condition. For
instance, a woman’s overall score on the Pelvic Floor
Distress Inventory (PFDI), a validated QOL instrument
specific for incontinence, prolapse, and colorectal dysfunc-
tion, may not improve after successful pelvic reconstructive
surgery due to the woman having significant distress from her
bowel symptoms. As a result, these measures do not
necessarily correlate with patient satisfaction after surgery,
and research in reconstructive pelvic surgery has shifted to
patient’s goals for surgery andmore global outcomemeasures.
Global indexes have been developed which ask patients
to rate their overall symptom improvement after treatment
[123, 124]. Global indexes are typically short and provide
the physician with an overall assessment of the patients’
symptoms since treatment. The Patient Global Impression
of Improvement (PGI-I) is a transition scale that has been
validated after stress incontinence treatment in women
[124]. (Table 4) The PGI-I was modeled after previously
published psychopharmacologic scales by changing the
stem to apply to LUT conditions [125]. The PGI-I is
increasingly used to assess outcome after incontinence
treatment [126, 127]. It is the primary outcome measure in
a large, national, randomized trial, the Refractory Urge
Incontinence and Botox Injection trial, sponsored by the
Pelvic Floor Disorders Network and the National Institute
for Child Health and Human Development.
Research in reconstructive pelvic surgery reflects the
trend towards patient expectations and goal selection in
determining surgical outcomes. Hullfish et al. [128]
reported long-term follow-up of patient-centered goals after
reconstructive pelvic surgery. Goal achievement remained
high 1–3 years after surgery and was significantly associ-
ated with condition-specific quality of life measures.
Women who experienced postoperative complications were
less likely to achieve their goals. Patient satisfaction after
reconstructive pelvic surgery correlated highly with
achievement of self-described, preoperative surgical goals,
while objective measures of surgical success correlated
poorly with patient satisfaction [127]. Patient dissatisfaction
was also highly associated with retrospectively feeling
unprepared for surgery and routine postoperative events.
One-year follow-up of this cohort demonstrated a high
correlation between patient dissatisfaction regardless of
goal achievement and developing overactive bladder
symptoms [129].
In conclusion, a global assessment of patients’ goals,
expectations for treatment, and postoperative symptoms are
recommended in both clinical practice and research to
further aid our understanding of treatment outcomes.
Urodynamic testing
Edward Stanford, Gunnar Lose
Role of UD testing
The role of urodynamic testing (UD) includes discriminat-
ing between different types of stress urinary incontinence
(SUI), diagnosing the severity of SUI, and identifying
concomitant complicating factors such as outlet obstruction,
detrusor hypoactivity, and detrusor overactivity. Ideally,
comprehensive preoperative evaluation under standardized
conditions should correctly identify patients with SUI. The
goal therefore, of urodynamic testing is to provide objective
confirmation of the signs and symptoms of lower urinary
tract dysfunction (LUTD) [130]. While the diagnosis and
optimal treatment of LUTD requires a careful history and
objective evaluation, it has been demonstrated that urinary
symptoms are not specific in predicting the dysfunction
involved in the patient’s incontinence [131–133]. Accord-
ing to expert consensus opinion, UD is the only way to
understand why people are continent or incontinent because
an attempt to gain that understanding is what constitutes
urodynamics.
Urodynamic testing
Pad testing, questionnaires, evaluation of urethral hyper-
mobility, and post-void residual (PVR) are referred to
elsewhere in this article.
Table 4 Patient Global Impression of Improvement (PGI-I)
Check the one number that best describes how your urinary tract
condition is now, compared with how it was before you began
treatment
Rating Description
1 Very much better
2 Much better
3 A little better
4 No change
5 A little worse
6 Much worse
7 Very much worse
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Uroflowmetry and post-void residual (optional)
Uroflowmetry measures urinary flow time, flow rate,
voided volume, and average flow rate. Post-void residual
(PVR) measures the quantity of urine remaining in the
bladder after voiding. The clinical utility of uroflowmetry
measurements may be predictive of postoperative voiding
dysfunction. Postoperative voiding function is predictably
worse when preoperative voiding difficulties exist. Preop-
erative uroflowmetry showing voiding abnormalities such
as Valsalva voiding or low flow rates may predict abnormal
symptomatic voiding dysfunction postoperatively [134].
Furthermore, bladder emptying can be affected by age,
medication use, fluid intake, and restriction, and voiding
habits.
Uroflowmetry and PVR are simple, noninvasive voiding
measures that should be performed on all patients with
incontinence or voiding dysfunction. If abnormal, those
tests should be repeated to document the reliability of the
result.
Cystometry (recommended)
Cystometry (CMG) is the most accurate tool for the
evaluation of bladder function with filling [135]. Simple
office-based CMG may yield sufficient information to
proceed with treatment and is therefore recommended. A
positive cough stress test and single-channel CMG may be
the minimally accepted tests before intervention [136].
Complex single-channel and multichannel CMG
requires specialized, expensive equipment, and training
to properly interpret the findings. Advantages are that
fluid-filled CMG allows determination of pressure-related
fluid loss, estimation of leak pressures, and simultaneous
measures of multiple variables. The repeatability of
measurements may be poor especially in non-neurogenic
patients; therefore, repeated measures are suggested to
establish bladder capacity and pressures [137]. This
invasive test is recommended, especially if complicating
factors are suspected.
Pressure flow study (optional)
Pressure flow (PF) measures the relationship between
pressure in the bladder and urine flow rate during emptying
and, hence, provides information about detrusor contractil-
ity and bladder outlet obstruction. It is recommended to
investigate voiding dysfunction, specifically in those
patients who had previous incontinence surgery and those
with high residual urine volume.
Urethral pressure profilometry (optional)
Urethral pressure is defined as the fluid pressure needed to just
open a closed (collapsed) urethra [138]. Conceptually, urinary
leakage will not occur at any abdominal pressure under
normal conditions. The main criticisms of urethral pressure
measurements are that they do not discriminate urethral
incompetence from other disorders, do not provide a
measure of severity of the condition, and do not provide a
reliable indicator to surgical success [134]. UD measure-
ments of the urethra quantify urethral length and pressures
relative to the bladder and abdominal pressures, as a means
of quantifying the continence mechanism. Urethral pressure
profilometry (UPP) are clinical tests that evaluate the
functional status of the urethra in women, measuring
intraluminal pressure along the length of the urethra. Studies
include maximum urethral closure pressure (MUCP), func-
tional urethral length (FUL), pressure transmission ratio
(transmission index) (PTR), and leak point pressure (LPP).
MUCP is an expression of the permanent acting closure
forces, which includes the submucosa, the smooth muscle,
the striated muscle, fibroelastic structures, and neural stimuli.
MUCP is generally lower in incontinent women and
decreases as a function of age [139]; however, there is a
considerable overlap of measured values compared to
continent women [140]. MUCP values in women with prior
anti-incontinence surgery are typically lower [141].
The MUCP is a static UD measurement; therefore, it has
been suggested that the UPP has limited clinical utility in
the routine evaluation of the SUI patient [142, 143].
Defining the urethral closure mechanism, standardization
of the methods of measurement of urethral pressure, the
type, size, material used in the catheter, and orientation of
the sensor within the urethra pose difficult questions in
standardizing urethral pressure measurements. Weber con-
cluded that due to the lack of standardization, urethral
pressure profilometry is not a useful diagnostic tool for
stress incontinence in women [144]. One conclusion is that
its use in clinical management is not supported by current
evidence, and many consider urethral pressure measure-
ments to be a research tool.
Conversely, ignoring urethral pressure measurements may
lead to a less successful surgical intervention in patients with
SUI. Sand et al. [145] proposed a cutoff value of <20 cm
H2O, as the subjective cure rate for a Burch retropubic
colposuspension was lower (46%) compared to patients with
an MUCP of >20 cm H2O (82%) in women over age 50. In
addition, various forms of voiding dysfunction related to
abnormal urethral function deserve attention in the clinical
setting [146]. The clinician needs to individualize the care of
the patient with SUI and decide whether urethral pressure
measurements play a role in their treatment.
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Leak pressures (optional)
McGuire et al. [147] first introduced the term, low pressure
urethra when he described the detrusor leak point pressure
(DLPP). The DLPP measures the resistance of the urethral
sphincter relative to detrusor pressure and is useful in
applying a pressure-based management approach to avoid
renal deterioration in patients with myelodysplasia or spinal
cord injuries.
The abdominal leak point pressure (ALPP) is defined as
the intravesical pressure at which urine leakage occurs due
to increased abdominal pressure in the absence of a detrusor
contraction [116]. If the patient has a filling CMG that is
negative, the ALPP is a useful provocative UD test that
accurately recreates the circumstances associated with stress
incontinence [148]. The ALPP therefore, has a role in
understanding and defining urethral function during a
Valsalva stress maneuver. The ICS does not define cutoff
values qualifying low-pressure urethra, and the term ISD,
or intrinsic sphincteric deficiency, is considered arbitrary.
Typically, an ALPP of <60 cm H2O indicates intrinsic
sphincteric dysfunction.
Prolapse
It is argued that 36–80% of women with advanced prolapse
have potential incontinence and should undergo urodynam-
ics before surgery [149]. Reduction of prolapse to uncover
potential (occult or latent) incontinence masked by the
prolapse is imperative [96, 150, 151]. Various techniques
have been employed including vaginal pack, pessaries,
rectal swabs, and Graves or Sims speculums [152–154].
Outcomes and UD testing
The ultimate goal of clinical urodynamics is to improve the
basis of choosing the correct therapy and, hence improve
outcome. In complex incontinence cases, multichannel UD
testing is recommended to establish a baseline understanding
of the pathophysiology. This is especially important before
invasive treatment is carried out. A standardized approach to
diagnosing patients with SUI is lacking; therefore, various
parameters have been investigated in varied combinations to
diagnose the patient’s incontinence and voiding dysfunction,
including ICI guidelines [130], AHCRP guidelines [155],
positive stress tests [156, 157], urethral hypermobility [156–
158], maximum bladder capacity >400 ml [157], residual
urine <50 ml [156–158], residual urine <200 ml [156], no
previous surgery [156–158], age under 65 [156], and
predominant stress incontinence by history [130, 156–159].
Comprehensive reviews conclude that the patient’s history is
inadequate in providing an accurate diagnosis, may lead to a
misdiagnosis in up to 25% of cases, may not be predictive of
the final diagnosis, and should not be used as the sole
determinant of diagnosis or treatment [160–161].
It has been argued for over 30 years that without some
form of objective urodynamic assessment, some patients
will be subjected to unnecessary or ineffective surgery
[162], and potential adverse outcomes, and surgical
complications (hemorrhage, hematoma, bladder injury,
urinary tract injury, urinary retention, failed surgery, and
postoperative urinary dysfunction) may be avoided. Jarvis
et al. [55] showed that clinical diagnosis was over-
diagnostic of detrusor overactivity and under-diagnostic of
SUI confirmed by UD testing. Moreover, when only
symptom-based treatments are considered, outcome may
be poorer in incontinent women [163]. Therefore, current
standards suggest that patients with complicated patho-
physiology should undergo some form of objective UD
testing before treatment, particularly surgical treatment.
Invasive-urodynamics is recommended in women if:
– Invasive or surgical treatment is considered
– Previous treatment for incontinence (surgical or non-
surgical) has failed
– Voiding dysfunction
– Neurologic disorder
– Unexplained incontinence.
However, patients with SUI as the dominant symptom
will likely demonstrate genuine stress incontinence on UD
testing. Thompson et al. [164] questioned the role of UD in
SUI and found that in women <50 years, urodynamic
evaluation was not predictive of outcome. A Cochrane
Database review concluded that current data is lacking to
determine if urodynamics affected clinical outcomes and
that a larger definitive comparative trial is needed [165].
There is some evidence that MUCP or leak point pressure
and detrusor overactivity predict persistent stress inconti-
nence and postoperative urgency, respectively [166]. Pa-
tient satisfaction rates are lower in women who develop
detrusor overactivity postoperatively [167, 168]. Patients
with low urethral pressures may demonstrate detrusor
overactivity after surgical correction and may go undetected
until urethral pressure is restored [169]. Therefore, in some
patients, UD testing plays an important role in predicting
postoperative detrusor function.
Conclusions and recommendations
UD testing, despite certain limitations, continues to be the
gold standard to define the pathophysiology of LUTD. It is
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argued that UD testing is not cost effective, limits access to
specialty care, and requires specialized and expensive
equipment, special training, and interpretation skills [169].
It is difficult and perhaps not appropriate to recommend
universal testing in all patients when considering the
uncomplicated forms of urinary incontinence. Symptoms,
questionnaires, voiding diaries, physical examination, and pad
testing are not predictive of the final diagnosis and may lead to
misdiagnosis; thus, UD testing is considered by many to be an
essential component of the work-up of the incontinent patient.
Noninvasive urodynamics (post-void residual volume
determination and possibly uroflowmetry) is recommended
in all incontinent patients for both practice and clinical
research. Multichannel urodynamic studies are recommen-
ded if planned treatment is irreversible, especially in those
with mixed incontinence and those who have symptoms or
signs of voiding difficulty as well. However, in those
patients whose predominant symptom is stress inconti-
nence, UD testing may not be necessary.
Invasive urodynamics is recommended in women if
invasive or surgical treatment is considered, surgical and
conservative treatment fails, or in cases of voiding dysfunc-
tion, neurologic disorder, or unexplained incontinence.
Neurophysiological testing of the pelvic floor
for the diagnosis of stress urinary incontinence
Kimberly Kenton
Electrodiagnostic (EDX) testing of the pelvic floor is
becoming increasingly common in clinical pelvic medicine
and pelvic floor research. Clinically, it can be used with
history, physical examination, and urodynamic testing to aid
in the diagnosis of certain pelvic floor disorders and to
determine if a central or peripheral neurologic problem
exists. Electrodiagnostic testing is also emerging in studies
investigating the etiology of pelvic floor disorders. A basic
understanding of the principles and techniques used in EDX
medicine are essential for reconstructive pelvic surgeons.
The aim of this discussion is to introduce reconstructive
pelvic surgeons (urogynecologists, urologists, and colorectal
surgeons) to the principles of neurophysiologic testing and to
the relevance of neurophysiologic testing in the pelvic floor
and urinary incontinence.
Pudendal and perineal nerve conduction studies
Clinical applications
Pudendal nerve conduction studies (NCS) are the most
commonly reported EDX tests done on the pelvic floor.
Pudendal and perineal NCS established the link between
pudendal neuropathy and stress urinary incontinence and fecal
incontinence [170–174]. Prolonged terminal motor latencies
have also been shown after vaginal incontinence and
prolapse surgery, [175, 176] suggesting that some anterior
vaginal wall dissection leads to distal pudendal nerve injury.
Pudendal nerve terminal motor latencies (PNTML) are most
frequently reported in case series of women undergoing anal
sphincteroplasty. Authors reported varying degrees of post-
operative success in patients with prolonged PNTML [177–
179]. The clinical usefulness of pudendal and perineal nerve
terminal motor latencies is hotly debated. They should not be
used in isolation from other EDX tests when evaluating
pelvic floor injuries. Generally, EMG follows NCS, as EMG
is more sensitive for detecting neuropathic injury.
Sacral reflex testing
Clinical applications
Urethral–anal and bladder–anal reflexes involve visceral
afferent fibers from the urethra or bladder, which synapse in
the conus medullaris and travel through pudendal efferents
to the external anal sphincter. Injuries to the pelvic plexus
or cauda equina frequently result in absence of the urethral
and bladder–anal reflexes. The clitoral–anal reflex passes
through the pudendal afferents to the spinal cord and back
through pudendal efferent fibers to the anal sphincter. These
roots are often affected in cauda equina disease and are not
affected in conditions that disrupt the pelvic plexus.
Anything that affects the pelvic plexus can potentially
disrupt the urethral and bladder–anal reflexes, such as
peripheral neuropathies with significant autonomic compo-
nents and radical pelvic surgery or radiation. The clitoral–
anal reflex should be preserved because the course of this
branch is not involved. Pudendal neuropathy typically results
in prolonged or absent clitoral–anal reflex with preservation
of the urethral and bladder–anal reflexes. The afferent limb
of the pathway through the pelvic plexus is less affected and
is a temporally longer portion of the pathway. Lesions in the
conus medullaris and cauda equina frequently produce
abnormalities in all sacral reflexes. Suppression of the
urethral–anal reflex by actively trying to void is a measure
of upper motor neuron function [180]. If a patient is unable
to suppress the response during voiding, she may have a
lesion in the suprasacral spinal cord.
Electromyography
EMG is the gold standard for studying peripheral striated
neuromuscular disease. It involves the recording and study
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of electrical activity from striated muscles and can be used
to distinguish between normal, denervated, denervated and
reinnervated, and myopathic muscle. The electrical activity
can be recorded using surface or needle electrodes.
Voluntary electrical activity is recorded as motor unit action
potentials (MUAP), which represent the summation of
activity from multiple motor units. Motor units are
comprised of a single anterior horn cell, its axon, and all
the skeletal muscle fibers it serves.
The most common electrodes used in the pelvic floor are
surface and concentric needle (CNE). Surface electrodes are
placed on the skin over the muscle being evaluated to
evaluate patterns of muscle activity and are commonly used
during urodynamic studies to assess urethral sphincter
activity. However, neuromuscular activity from multiple
pelvic floor muscles is recorded, not just the striated
urethral sphincter, making it difficult to differentiate which
muscle is contributing to the signal. A recent study
comparing perineal surface to urethral CNE during urody-
namics demonstrated that CNE tracings were consistently
more interpretable than surface recordings [181]. Needle
tracings demonstrated urethral relaxation with voiding 79%
of the time, while surface recordings only demonstrated
urethral relations 28% of the time.
Three types of activity can be recorded with CNE—
insertional, spontaneous, and MUAPs. Insertional activity
is the electrical activity detected by the CNE as it passes
through the muscle at rest. Decreased insertional activity
indicates that the electrode is not in muscle or the muscle
has undergone severe atrophy and replacement by electri-
cally inactive tissue. This is commonly seen in the anal
sphincter at the 12 o’clock position in women with long-
standing anal sphincter disruptions.
Spontaneous activity is persistent electrical activity after
the CNE is inserted and results from marked membrane
instability of the muscle or neuron innervating it. Fibrilla-
tion potentials and complex repetitive discharges (CRDs)
are common types of insertional activity. Complex repeti-
tive discharges are associated with neuropathy and voiding
dysfunction in women. Fowler’s syndrome, first described
in 1985, is the triad of urinary retention, urethral CRDs, and
polycystic ovaries in young women [182]. Retention in this
group of patients is thought to be due to “overactivity” of
the striated urethral sphincter, due to direct spread of
electrical excitation from muscle fiber to muscle fiber.
Motor unit action potential analysis in the sphincters can
be done at rest and with voluntary activity. Nerve injury
results in characteristic changes in MUAP parameters of
duration, amplitude, and polyphasia. After nerve injury, a
muscle fiber can be reinnervated by regrowth of the original
axon or a nearby axon. If a nearby axon reaches the
denervated muscle fiber, it will supply more muscle fibers
creating a more complex MUAP. The new complex
waveform tends to be polyphasic (number of times a
MUAP crosses the baseline). New axons are initially not
well myelinated and conduct impulses more slowly; as a
result, newly reinnervated muscle has long duration
MUAPs. The MUAPs have larger amplitudes, as one motor
unit is supplying more muscle fibers.
Clinical applications
Concentric needle EMG has been used in pelvic floor
muscles to confirm the association between pelvic nerve
injury and vaginal delivery, stress incontinence, and fecal
incontinence. Significant changes in MUAP morphology
have been reported after vaginal childbirth by multiple
authors [183–185]. Needle EMG of the levator ani and
external anal sphincter muscles has shown EMG evidence
of denervation with reinnervation in women with stress
urinary incontinence and pelvic organ prolapse [185, 186].
Two studies have used quantitative CNE of the urethral
sphincter in women undergoing continence surgery [187,
188]. Fisher et al. [187] demonstrated more advanced
neuropathic changes in women with persistent stress
urinary incontinence. Kenton et al. [188] studied 89 women
undergoing Burch urethropexy with CNE and found
significant differences in EMG parameters of women with
successful incontinence surgery, suggesting that these
women had better innervation of their urethral sphincters.
Gregory recently reported quantitative CNE data from
the anal sphincter of 23 nulliparous and 28 vaginally parous
women. Motor unit action potentials from the 23 nulliparas
had significantly higher amplitudes, longer durations, and
more phases, lending further evidence that vaginal child-
birth results in pudendal neuropathy [184]. Some normative
CNE MUAP parameters have been reported for the external
anal sphincter and levator ani [185, 189]. No normative
data exists for the striated urethral sphincter.
Conclusions and recommendations
Electrodiagnostic testing has both clinical and research
applications in pelvic floor disorders. Clinical evidence
suggests that certain types of reconstructive surgery may
impact pelvic floor innervation. Zivkovic measured perineal
nerve terminal motor latencies before and after vaginal
reconstructive surgery and found significantly prolonged
terminal motor latencies in women who underwent vaginal
needle suspension procedures [176]. Similarly, Benson
found significantly prolonged pudendal and perineal nerve
terminal motor latencies in women undergoing vaginal
prolapse repair, while the terminal motor latencies of
women undergoing abdominal repair were not different
[190]. Pudendal neuropathy was significantly more com-
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mon in the women with “suboptimal” repairs [191]. In a
randomized trial of abdominal vs vaginal reconstructive
surgery, Benson found superior anatomic results of prolapse
repair in the abdominal group [175]. Another randomized
trial also demonstrated anatomic superiority of the abdom-
inal approach [192]. These data suggest that vaginal
reconstructive surgery may result in denervation of the
pelvic floor musculature, which impacts anatomic success
of the surgery. There is also increasing data that preoper-
ative pelvic floor denervation may impact surgical out-
comes, particularly for continence procedures. Two recent
studies demonstrated a relationship between urethral
sphincter neuropathy and outcome of continence surgery
[187, 188].
Pelvic floor EDX studies may aid in the clinical diagnosis
of some pelvic floor disorders and help to predict outcomes
of incontinence surgery. However, confirmatory studies are
necessary. In a neurologically normal patient, electro-
diagnostic testing is not recommended for clinical research
or practice to evaluate female stress urinary incontinence.
Surgical complications in the treatment of stress urinary
incontinence
Edward Stanford, Eckhard Petri
Introduction
The operative approach to correct stress urinary incontinence
(SUI) may include abdominal, vaginal, laparoscopic, and
combined procedures. In addition, different materials used in
the procedure may include autologous tissue (rectus fascia
and tensor fascia lata), xenografts (porcine dermis, porcine
intestinal submucosa, bovine pericardium, and others),
synthetic grafts, and combined synthetic and biologic grafts.
Pelvic surgeons should be skilled in the prevention, early
detection and correction of surgical complications [193].
Incidence
It appears that the risk of LUT injury is similar for vaginal,
abdominal, and laparoscopic surgical approaches, although
the risk of LUT injury during laparoscopy appears to
increase with the increasing complexity of the procedure.
Complications listed below related to SUI surgical proce-
dures can potentially involve any of the organs of the pelvis.
– Bladder injuries
– Urethral injuries
– Ureteral injuries
– Intestinal injuries
– Erosions
– Hemorrhage
– Fistulae
– Prolapse
– Voiding dysfunction
– Postoperative OAB
– ISD
– Recurrent incontinence
– Dyspareunia
– Pain
Lower urinary tract injury
The actual incidence of injury during Burch colposuspen-
sion is unknown. Ureteric injury, retroperitoneal urinoma,
and ureteral ligation are reported [194–197]. Urethra injury
is relatively uncommon with the Burch procedure. Bladder
injury is more common with laparoscopic Burch, with one
study reporting a 2.3% incidence of cystotomy (4 of 171;
[198]).
Intravesical sutures have been reported in almost all SUI
surgical procedures [199]. These patients often present with
bladder or pelvic pain, frequency, urinary tract infection, or
recurrent incontinence. Stevenson et al. [200] reported a 9%
incidence of intraoperative bladder or ureteral injury during
the Burch procedure, many of which are recognized after
surgery, arguing that cystourethroscopy is recommended to
visualize the bladder and urethra during surgery to avoid
this surgical complication.
Unfortunately, we can only rely on isolated reports
occasionally published in the surgical literature to get an idea
of the incidence and severity of complications. Miscellaneous
complications reported after the Burch procedure, include
massive hemorrhage requiring transfusion, hematoma, blad-
der injuries diagnosed intraoperatively and postoperatively,
ureteral kinking, urinary retention, wound infection, pelvic
abscess, UTI, and DVT [201]. Similarly, a university
teaching program reported complications from 151 open
Burch procedures over a 5-year period, which included LUT
injury <1%, cystotomy 1.3% (N=2), intravesical suture 0.7%
(N=1), transfusion 0.7% (N=1), postoperative ileus 1.3%
(N=2), incisional complications 3%, of which five had
cellulites, and one suffered an incisional separation, urinary
retention 0.7% (N=1), and de novo detrusor overactivity 8%
[202]. Paraiso et al. [203] reported an 8% risk of
unrecognized injury with Burch which included two intra-
vesical sutures, one bowel injury, one hematoma, one pelvic
abscess, one postop ileus, one pulmonary embolus, one
pyelonephritis, two with recurrent incontinence requiring
collagen periurethral injections, and a 34.5% incidence of
detrusor overactivity treated with anticholinergics.
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Voiding dysfunction
Voiding dysfunction such as frequency, nocturia, urgency
with and without incontinence, hesitancy, retention, incom-
plete emptying, and recurrent urinary tract infections have
been reported after all anti-incontinence procedures. Voiding
dysfunction after retropubic colposuspension and mid-ure-
thral sling procedures is usually transient and resolves
postoperatively [204, 205]. The incidence of de novo
detrusor overactivity and urge urinary incontinence varies
depending upon the anti-incontinence procedure with rates
as high as 33%. Comparing retropubic vs TO slings, the
incidence of urge urinary incontinence and detrusor overac-
tivity rates are lower after TO slings [206]. Patients with
detrusor pressures less than 15 cm H2O are at risk for
postoperative urinary retention [204]. After tension-free
vaginal tape (TVT), voiding dysfunction can be as high as
26%, requiring >24 h of catheterization in 11% and tape
division in 1.3% (207).
Extrusion and erosion
It is argued that the actual incidence of complications is not
known due to underreporting, and studies comparing success
rates, complications, and erosion rates are lacking [208]. It is
clear, however, that after all anti-incontinence surgeries,
erosion and migration of suture material, bolsters, supporting
tacks, and synthetic mesh material can occur. Bone anchor
material is used less often due to reports of osteitis pubis and
osteomyelitis at times requiring osteotomy and removal.
The type of mesh material used in mid-urethral slings and
prolapse surgery is of importance as some materials
demonstrate higher erosion and extrusion rates than others.
Higher rates are reported with synthetic mesh that is woven
with small pore size, as macrophage migration to deposit
collagen and engulf bacteria is hindered (e.g., ObTape and
GoreTex). Fortunately, these materials have been replaced
with loosely knitted, macroporous (>75 uM), monofilament
polypropylene material with lower complication rates [209].
Mesh extrusion is usually treated with local excision in
the office setting. However, erosion of materials used can
become a major complication. At times, extensive surgery
may be necessary and may involve retropubic, vaginal,
intravesical, and abdominal approaches, at times, resulting
in considerable morbidity. Deng et al. [210] report on 26
urethral and bladder erosions treated with a combination of
urethrolysis with mesh removal, urethral reconstruction
with graft, and bladder excision.
Failure
Recurrent SUI, both short-term (1-year) and long-term
(5-years) varies depending upon the anti-incontinence
procedure. Bhatia and Bergman [211] reported on the
objective success rates for a modified Burch (98%) vs a
Pereyra needle suspension (82%) at 1-year performed for
SUI. A 5-year follow-up reported objective continence rates
after three procedures: anterior colporrhaphy (37%), Per-
eyra procedure (43%), and the modified Burch retropubic
colposuspension (82%) [212]. It appears that mid-urethral
slings, both TVT and TO approaches, will demonstrate
lower SUI recurrence; however, long-term follow-up
studies are forthcoming.
Complications of sling urethropexy procedures
Sling urethropexy procedure can be performed via different
approaches which influences the type of complications
encountered. (Table 5) Complications reported for the sling
urethropexy include erosion of sling material, bladder and
urethral laceration, urethral amputation, and urethrovaginal
and vesicovaginal fistulae.
In the previously mentioned report by Paraiso et al., the
TVT procedure was compared to the Burch. Complications
in the TVT arm included two cystotomies, one blood
transfusion, one hematoma, one pelvic abscess, two with
retention requiring mesh transection, one vaginal erosion,
and 23.5% requiring anticholinergics for urge urinary
incontinence. The 1-year success rate as per urodynamic
testing was 96.8%. Comparatively, urge urinary inconti-
nence or detrusor overactivity are probably less after
transobturator (TO) approaches [215].
Prevention
There is no substitute for good surgical training, a thorough
preoperative history and diagnostic work-up to recognize
risk factors, and a permanent awareness of the close
proximity of the urinary tract, bowel and major neuro-
vascular bundles in the pelvis. Most intraoperative LUT
Table 5 Potential complications: sling urethropexy
Ascending retropubic
approach
Risks: bladder, intestinal and vascular
injury
Descending retropubic
approach
Risks: bladder perforation, vascular
injury
Mixed retropubic approach Risks: same for ascending and
descending approaches
Transobturator approach Risks: bladder perforation, urethral
injury, vaginal perforation
Fascial slings Risks: pain, hematoma, infection
Bone anchor slings (213) Risks: pain, osteitis
Silicone-coated polyester
suburethral sling
Risks: vaginal extrusion of the sling
material (214)
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injuries occur during otherwise uncomplicated procedures,
and injuries occur even in the “best of hands”. Routine
preoperative evaluation with renal and pelvic sonogram,
intravenous pyelogram, and cystourethroscopy are not uni-
versally available and may be cost prohibitive. However, a
prudent and directed work-up may warrant their use. Most
important is the proper selection of patients for the chosen
procedure with care and attention to detail in the performance
of the procedure following standardized techniques. Nilsson
et al. [216] showed in Finland that TVT sling complications
exceeded 30% with less than 20 procedures that were
performed per year, not being reduced beyond a level of
15–18% with more than 40–80 procedures performed.
Dwyer et al. [199] demonstrated that intraoperative
cystoscopy may not detect the presence of intravesical sutures.
In a study by Kuno et al. [217], the use of prophylactic
ureteral catheters did not affect the rate of ureteral injuries. A
low incidence of urinary injuries can only be attributed to
meticulous surgical techniques. This seems to be of increasing
importance for those institutions in favor of laparoscopic
hysterectomies and incontinence or prolapse surgery.
Diagnosis and treatment
Immediate recognition and correction is the best option for
resolution of surgical complications. Naturally, the appro-
priate treatment is dependent upon the type of complication
encountered. Unfortunately, diagnosis is made after the
operation in more than two-thirds of the patients. Any
atypical postoperative symptoms, such as prolonged mod-
erate temperature and/or diffuse pain should always prompt
a work-up. Renal sonography, intravenous pyelography,
cystometrogram, computed tomography (CT) or MRI
scanning, cystourethroscopy, ureteral stenting, or an intra-
vaginal examination to rule out injury, perforation, lacera-
tion, hydronephrosis, ureteral ligation, hematoma, bleeding,
or fistula may be required.
Symptoms and signs are variable, depending upon the
location and the etiology. Direct lacerations lead to early
leakage of urine; devascularization may delay diagnosis
from 10–12 days up to several months. In a group of 72
women with 77 ureteral lesions, the interval to diagnosis
was more than 10 days in 50% of the patients [218].
Conclusions and recommendations
As described above, the best treatment is prevention and
early recognition of surgically related injury or postopera-
tive complications. This implies either adequate skills of the
surgeon himself to perform reconstruction or easy access to
trained surgeons who can assist. It must be recommended to
carefully select procedures depending upon the surgeon’s
skills and the capabilities of the institution. All complica-
tions (early and delayed) should be reported in research
and clinical practice.
Cost effectiveness in incontinence research
Safwat Tosson
Introduction
It is expected that the aging population will increase, and
therefore, the number of cases of incontinence will increase.
Most health care markets have limited resources [219], and
clinicians will have to compete for these resources to treat
their patients. Therefore, cost effectiveness research is
important to be able to provide continence services, and help
both physicians and their patients make informed choices.
Measuring costs
Accounting and billing systems may be able to measure
“gross costing” and “micro-costing” [220]; however; they
are not available in all health care systems, and they do not
measure the entire cost of the condition. Different account-
ing systems may give different cost estimates, and they do
not measure the social costs and burden.
Categorizing costs
Costs may be categorized into the following:
– Measurement of direct cost “value” of all goods and
services and other resources used to treat the condition
and the consequences of incontinence [221]. This
includes diagnosis, treatment, incontinence pads, and
consequences of the condition.
– Indirect costs, including the value of lost productivity
or morbidity.
– Intangible costs, including pain and suffering.
Economic analysis
There are many methods of economic analysis of health
care, including:
1. Incontinence-specific outcomes, including urodynamics,
pad test, urinary diaries, etc.
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2. Health starters and quality of life measurements, such
as the SF-36 Nottingham Health Profile, The World
Health Organization Quality of Life, and others.
3. The “value” of pelvic floor health may also be measured
economically and include measurement of a willingness
to pay (WTP), which showed that the willingness to pay
was significantly related to the degree of reduction in
incontinence episodes [222]. The Disability Adjusted
Life Year (DALY) is based on the years of life lived with
disability and the years of life lost due to premature
death; it was formulated to determine a correlation
between disease burden and cost of health care to treat it
[223, 224]. The Quality Adjusted Life Year (QALY)
[225–228] is the relationship between the value of a
given health state and the length of time a person lives in
this health status. The person measures the value of
intervention in relation to live–death state. This measure
also enables health economists to compare between
various disease conditions and interventions.
4. Very few studies included QALY’s parallel to random-
ized studies to evaluate surgical or medical intervention
[229–230]
Recommendations
Most studies include direct cost analysis because they
measure costs from the perspective of the health provider
and not the patient, and exclude both the patient’s and
physician’s born costs. Cost analysis should be made in
current year dollars. It is recommended that quality cost
effectiveness research is included in randomized studies. It
would be beneficial for decision makers if QALY is used
more often in future research.
Summary of recommendations
The IUGA guidelines were written by a consensus of IUGA
members and experts in the field as recommendations for
practice and are not meant to substitute for good clinical
judgment nor replace the unique physician–patient relation-
ship. They were developed to facilitate communication
between physicians working in the field, and help to
standardize research measures and allow comparison between
different studies. They are meant to be categorical to allow for
individual and global variations. As there is disagreement in
the literature throughout these guidelines, the corresponding
rating schemes and strength of the evidence were not
included. The IUGA guidelines for SUI evaluation for both
clinical practice and research are not legally binding and are
subject to future revision.
Suggestions for reviewers
For research papers reporting on surgical treatment out-
come and submitted for publication, at least 1 year follow-
up is recommended. Shorter periods of follow-up should be
used only to report on technical feasibility, safety, intra-
operative and immediate postoperative complications.
Abstracts may contain early outcome of at least 6 months.
Definition of SUI treatment outcome
Should include all aspects of the disease, usually a
combination of subjective and objective measures, and
patient’s degree of satisfaction/quality of life.
Summary of IUGA recommendations for SUI outcome
measures
Parameter Clinical
practice
Research
Clinical evaluation R R
Voiding diary O R
Cough stress test R R
Empty supine stress test O O
Incontinence severity O R
Visual analog score N N
Stamey’s grading O O
Severity measures (e.g., Sandvik index,
UDI-6)
O R
Pad test (1 and 24 h) O R
Quality of life measures O R
General health questionnaires N O
Incontinence-specific questionnaires O R
Sexual dysfunction O R
Urethral/ bladder neck mobility R R
Q-tip O O
Perineal ultrasound O O
Prolapse anatomy R R
POP-Q R R
POP-Q staging or Baden-Walker half-
way grading
R R
Patient’s satisfaction and assessment R R
Expectations O R
Goals O R
Postoperative symptoms R R
Urodynamic testing R R
Post-void residual urine volume R R
Uroflow O R
Cystometry R R
Pressure flow O O
Urethral pressure profile O O
Leak pressure (abdominal and/or
detrusor)
O O
Electrodiagnostic testing N N
Reporting complications R R
Cost analysis N O
R Recommended, O optional, N not recommended
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